Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
159 hedge funds and large institutions have $723M invested in Meridian Bioscience Inc in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 41 reducing their positions, and 20 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 41
17% more capital invested
Capital invested by funds: $621M → $723M (+$102M)
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
5% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $1.41M
1% less funds holding
Funds holding: 160 → 159 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$17.2M |
| 2 |
Bank of New York Mellon
New York
|
+$14.8M |
| 3 |
PP
Prudential plc
London, England,
United Kingdom
|
+$4.79M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.32M |
| 5 |
GAM
Gotham Asset Management
New York
|
+$4.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.6M |
| 2 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$8.39M |
| 3 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
-$5.23M |
| 4 |
CPCM
Clifton Park Capital Management
Wilmington,
Delaware
|
-$4.33M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.96M |
VIVO Hedge Fund Activity: Q1 2015 in Review
159 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2015, worth a combined $723M — up 17% from $621M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new VIVO positions and 20 closed out — a net gain of 2 holders — while 64 added to existing stakes and 41 trimmed.
The largest buyer was Schroder Investment Management Group, adding an estimated $17.2M. The largest seller was Fidelity Investments, cutting an estimated $24.6M.
- 159 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2015, down from 160 in Q4 2014.
- Funds reported $723M of Meridian Bioscience Inc stock for Q1 2015, up 17% quarter-over-quarter.
- 22 funds opened new Meridian Bioscience Inc positions in Q1 2015 and 20 closed out, a net change of +2 holders.
- The largest Meridian Bioscience Inc buyer in Q1 2015 was Schroder Investment Management Group, an estimated $17.2M added.
- The largest Meridian Bioscience Inc seller in Q1 2015 was Fidelity Investments, an estimated $24.6M sold.
Based on aggregated 13F filings for Q1 2015.